Algiers

Algiers has solidified its position as a central hub for the pharmaceutical industry and life sciences innovation in North Africa.

The city is best known for hosting the Maghreb Pharma Expo, the continent’s largest platform for pharmaceutical technology, which attracts global leaders in biotechnology, cleanroom engineering and R&D.

Driven by the strategic initiatives of the Ministry of Pharmaceutical Industry, the ecosystem has seen a massive shift toward local manufacturing, with Algiers serving as the headquarters for major domestic and multinational producers.

Beyond traditional drug manufacturing, the capital is fostering a growing biotech hub focused on biosimilars and high-value specialty treatments to address chronic disease management.

The medical device sector is also expanding, supported by rigorous regulatory frameworks and a surge in private-sector healthcare facilities requiring advanced diagnostic tools.

At the heart of this progress is a robust academic research network, led by the University of Algiers, which produces a steady pipeline of talent in biological sciences and microbiology.

Healthcare innovation in the city is increasingly tech-enabled, as local health-tech startups and digital health platforms modernize patient care and market access.

International investors are drawn to the city's streamlined regulatory environment, where the National Agency for Pharmaceutical Products has significantly accelerated registration timelines for innovative therapies.

With a pharmaceutical market projected to exceed $1 billion in 2026, Algiers offers unparalleled opportunities for global partnerships in clinical research and industrial scaling.